Use of Doxycycline to Prevent Sexually Transmitted Infections According to Provider Characteristics

• Published in: Emerging infectious diseases Vol. 30; no. 1; pp. 197 - 199
• Main Authors: Pearson, William S, Emerson, Brian, Hogben, Matthew, Barbee, Lindley
• Format: Journal Article
• Language: English
• Published: United States U.S. National Center for Infectious Diseases 01-01-2024; Centers for Disease Control and Prevention
• Subjects: Anti-Infective Agents; Antibiotics; Antimicrobial agents; antimicrobial resistance; bacteria; Bacterial infections; Disease control; Disease prevention; Disease transmission; Doxycycline; Doxycycline - therapeutic use; Drug resistance; Drug resistance in microorganisms; Gonorrhea; Health Knowledge, Attitudes, Practice; Health surveillance; HIV Infections; Humans; Infections; Patients; Prevention; prophylaxis; providers; Regression analysis; Research Letter; Sexually transmitted diseases; Sexually Transmitted Diseases - epidemiology; Sexually Transmitted Diseases - prevention & control; Sexually transmitted infections; STD; Use of Doxycycline to Prevent Sexually Transmitted Infections According to Provider Characteristics; Atlanta Georgia; United States > US; Georgia; bacteria; United States; antimicrobial resistance; doxycycline; prophylaxis; providers; Sexually transmitted infections
• ISSN: 1080-6040; 1080-6059
• DOI: 10.3201/eid3001.231152

Use of doxycycline to prevent sexually transmitted infections (STIs) may lead to antimicrobial resistance. We analyzed attitudes toward this practice between US providers who commonly and less commonly treat STIs. Providers who more commonly treat STIs are more likely to prescribe prophylactic doxycycline and believe that benefits outweigh potential for increased antimicrobial resistance.